Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02833246

Enrollment

Registered

2016-07-14

Start date

2016-06-28

Completion date

2018-11-14

Last updated

2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung, Sarcoma, Solid Tumor Gastrointestinal

Keywords

texting, Adherence to Oral Anticancer Medications, 16-810

Brief summary

This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.

Interventions

OTHERSMS/MMS text messaging

text messaging reminders on oral chemotherapy medication adherence

OTHERusual care

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK. * Starting a new treatment regimen that includes a single oral anticancer medication * Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled. * Age 18 or older. * Ability to speak and read English because we do not have the resources to translate the text messages into other languages.

Exclusion criteria

* Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.

Design outcomes

Primary

Measure	Time frame	Description
objective pill count	1 year	is greater or less than the amount of OAM that the patient should have in their possession.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026